Long-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retina

Nanodiamonds were combined with niosome, and resulting formulations were named as nanodiasomes, which were evaluated in terms of physicochemical features, cellular internalization, cell viability and transfection efficiency both in in vitro and in in vivo conditions. Such parameters were analyzed at...

ver descrição completa

Detalhes bibliográficos
Autores: AL Qtaish, Nuseibah, Villate Beitia, Ane Ilia, Gallego Garrido, Idoia, Martínez Navarrete, Gema, Soto-Sánchez, Cristina, Sainz Ramos, Myriam, López Méndez, Tania Belén, Paredes, Alejandro Javier, Chichón, Francisco Javier, Zamarreño, Noelia, Fernández, Eduardo, Puras Ochoa, Gustavo, Pedraz Muñoz, José Luis
Tipo de documento: artigo
Data de publicação:2023
País:España
Recursos:Universidad del País Vasco
Repositório:Addi. Archivo Digital para la Docencia y la Investigación
OAI Identifier:oai:addi.ehu.eus:10810/61613
Acesso em linha:http://hdl.handle.net/10810/61613
Access Level:Acceso aberto
Palavra-chave:nanodiamond
niosome
non-viral
gene delivery
stability
retina
Descrição
Resumo:Nanodiamonds were combined with niosome, and resulting formulations were named as nanodiasomes, which were evaluated in terms of physicochemical features, cellular internalization, cell viability and transfection efficiency both in in vitro and in in vivo conditions. Such parameters were analyzed at 4 and 25 °C, and at 15 and 30 days after their elaboration. Nanodiasomes showed a particle size of 128 nm that was maintained over time inside the ± 10% of deviation, unless after 30 days of storage at 25 °C. Something similar occurred with the initial zeta potential value, 35.2 mV, being both formulations more stable at 4 °C. The incorporation of nanodiamonds into niosomes resulted in a 4-fold increase of transfection efficiency that was maintained over time at 4 and 25 °C. In vivo studies reported high transgene expression of nanodiasomes after subretinal and intravitreal administration in mice, when injected freshly prepared and after 30 days of storage at 4 °C.